hydrazine has been researched along with Hemorrhagic Disorders in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gauchan, D; Gedeon, D; Maroules, M; Shaaban, H | 1 |
| Daly, ME; Dawood, BB; Mumford, AD; Mundell, SJ; Murden, SL; Protty, MB; Spalton, JC; Watson, SP; Wheatley, M; Williams, MD | 1 |
| Clément, F | 1 |
3 other study(ies) available for hydrazine and Hemorrhagic Disorders
| Article | Year |
|---|---|
Use of eltrombopag for the treatment of thrombocytopenia in hypoplastic myelodysplastic syndrome.
Topics: Aged, 80 and over; Benzoates; Bone Marrow; Erythrocyte Transfusion; Female; Hemorrhagic Disorders; Humans; Hydrazines; Myelodysplastic Syndromes; Platelet Transfusion; Pyrazoles; Receptors, Thrombopoietin; Thrombocytopenia | 2014 |
A novel thromboxane A2 receptor D304N variant that abrogates ligand binding in a patient with a bleeding diathesis.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Triphosphate; Adolescent; Amino Acid Motifs; Amino Acid Substitution; Animals; Blood Platelets; Bridged Bicyclo Compounds, Heterocyclic; Calcium; CHO Cells; Cricetinae; Cricetulus; Cytosol; Fatty Acids, Unsaturated; Female; Gene Expression; Hemorrhagic Disorders; Humans; Hydrazines; Ligands; Male; Mutation, Missense; Protein Binding; Protein Structure, Tertiary; Receptors, Thromboxane A2, Prostaglandin H2; Vasoconstrictor Agents | 2010 |
[Symptomatic thrombopenias. Difficulties of early diagnosis and therapeutic possibilities].
Topics: Adult; Blood Platelets; Hemorrhagic Disorders; Hodgkin Disease; Humans; Hydrazines; Immunoelectrophoresis; Lupus Erythematosus, Systemic; Male; Middle Aged; Multiple Myeloma; Prednisone; Purpura; Splenectomy; Thrombocytopenia; Vinblastine; Waldenstrom Macroglobulinemia | 1966 |